Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Stage Set For India To Frame Compulsory Licensing Provisions As Contrasting Groups Make Their Case

This article was originally published in PharmAsia News

Executive Summary

MUMBAI - After soliciting views from stakeholders on a "discussion paper" to outline conditions in which a compulsory license could be invoked, India's Department of Industrial Policy and Promotion is now trying to figure out what to do

You may also be interested in...



Generic Drug Makers To Benefit From India Patent Disclosures

MUMBAI - India's patent office has decided to make public details about all patented drugs available in the country in an order to increase transparency in its pharma market, as well as boost the country's generic drug makers

Generic Drug Makers To Benefit From India Patent Disclosures

MUMBAI - India's patent office has decided to make public details about all patented drugs available in the country in an order to increase transparency in its pharma market, as well as boost the country's generic drug makers

India Maintains Status Quo On Compulsory Licensing Provisions

Indian generics industry, multi-national company lobbies welcome moves to keep flexibility, but doubts linger regarding future investments.

Related Content

UsernamePublicRestriction

Register

SC073430

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel